Krystal Biotech KRYS
NASDAQ KRYS
$326.29 +0.98 (+0.30%)
As of: Oct 2, 2026 · 12:40 PM EDT

Krystal Biotech (KRYS) Invested Capital (2016 - 2017)

Updated

Krystal Biotech's Invested Capital was $49.47 million in Q4 2017, compared with $987,000 a year earlier and down 1.4% from the prior quarter.

Analysis

Krystal Biotech (KRYS) Invested Capital (2016 - 2017) Analysis & Trends

  • In earlier years, Invested Capital was $987,000 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Krystal Biotech 9.84 Bn 6.61 Bn 112.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 49.47 Mn
Sep 30, 2017 50.20 Mn
Dec 31, 2016 987,000.00
API Access

Krystal Biotech Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=KRYS&period=max&api_key=YOUR_API_KEY